Showing 1,657 news articles about Hepatitis & HIV

Filters Content type: Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Hepatitis C treatment

Practical steps to eliminating hepatitis C: a consensus for London

Editor's pick
London Joint Working Group on Substance Use and Hepatitis C
17 November 2014
Hepatitis C treatment

Interim Revision of Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents

Editor's pick
AidsInfo
17 November 2014
Hepatitis C treatment

New HCV drugs pass muster in real world

Editor's pick
MedPage Today
11 November 2014
New & experimental hepatitis C treatment

New pill that can cure hepatitis C approved for patients in Scotland

Editor's pick
STV
11 November 2014
New & experimental hepatitis C treatment

Merck’s four-week treatment for hepatitis C misses the mark

Editor's pick
Wall Street Journal
11 November 2014
New & experimental hepatitis C treatment

Phase 3 UNITY Trials Demonstrate High Cure Rates for Investigational, All-Oral Daclatasvir TRIO Fixed-Dose Combination in Genotype 1 Hepatitis C Patients, Including Those with Cirrhosis

Editor's pick
Bristol-Myers Squibb press release
10 November 2014
New & experimental hepatitis C treatment

ALLY Trial Demonstrates High Cure Rates for Investigational Daclatasvir and Sofosbuvir Combination among Genotype 3 Hepatitis C Patients

Editor's pick
Bristol-Myers Squibb press release
10 November 2014
New & experimental hepatitis C treatment

Achillion Reports 100% SVR12 in a Phase 2 Combination Study With ACH-3102 at the Liver Meeting 2014 (AASLD)

Editor's pick
Achillion press release
10 November 2014
New & experimental hepatitis C treatment

Merck's Four-Week Hepatitis C Regimen Fails to Top Gilead

Editor's pick
Bloomberg
10 November 2014
Hepatitis C treatment

Olysio (simeprevir) approved for use in combination with sofosbuvir

Editor's pick
Johnson & Johnson press release
7 November 2014
Pharmaceutical industry

Bristol-Myers Plan to Widen Access to its Hep C Drug is Criticized

Editor's pick
Wall Street Journal
5 November 2014
Hepatitis C symptoms & diagnosis

Half of people with hepatitis C unaware

Editor's pick
Public Health England press release
5 November 2014
Hepatitis C treatment

Bristol-Myers Squibb announces HCV global access plans

Editor's pick
Bristol-Myers Squibb press release
3 November 2014
Hepatitis C transmission & prevention

Opioid Maintenance Therapy Linked to Lower Hepatitis C Rates for People Who Inject Drugs

Editor's pick
HIVandhepatitis.com
29 October 2014
Hepatitis C treatment

Australia's rejection of costly new treatment sofosbuvir a 'death sentence for for Hepatitis C sufferers'

Editor's pick
ABC Online
27 October 2014
Hepatitis C treatment

Ireland: Hepatitis C drug to be made available

Editor's pick
The Irish Times
22 October 2014
Hepatitis C treatment

Advocates Criticize Plans to Restrict N.Y. Hepatitis C Drugs

Editor's pick
Poz magazine news
22 October 2014
Hepatitis C transmission & prevention

HCV sexual transmission: HIV negative may be at risk, more awareness and testing needed

Editor's pick
HIVandHepatitis.com
16 October 2014
Hepatitis & HIV

Coffee, Even Decaf, May Promote Liver Health

Editor's pick
AIDSMeds
16 October 2014
New & experimental hepatitis C treatment

IDWeek 2014: AbbVie 3D HCV Regimen Well-tolerated in PEARL Trials

Editor's pick
HIVandHepatitis.com
16 October 2014
Hepatitis C treatment

Unique 'pay if you clear' proposal for new hepatitis drug

Editor's pick
BBC
15 October 2014
Hepatitis C transmission & prevention

Egypt: Poor infection control to blame for hepatitis C epidemic

Editor's pick
Nature Middle East
15 October 2014
New & experimental hepatitis C treatment

Fair Pricing Coalition Urges a Uniform Price for Curative Hepatitis C Treatment

Editor's pick
Fair Pricing Coalition
15 October 2014
Pharmaceutical industry

If AbbVie Discounts its Hep C Drug, Would Pricing Reach a Tipping Point?

Editor's pick
Wall Street Journal
15 October 2014